INVIMESTROCEL
UNII WNR9FH307P

Substance Identification & Data

This profile provides standardized clinical and technical data for Invimestrocel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WNR9FH307P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WNR9FH307P

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INVIMESTROCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C77874

National Cancer Institute reference terminology for clinical and research data.

INN ID

11238

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Invimestrocel

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Invimestrocel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Invimestrocel

Common Names & Synonyms

Invimestrocel (Allogeneic human multipotent adult progenitor cells (MAPC) derived from bone marrow and isolated by density gradient centrifugation. The cells are expanded ex vivo on fibronectin-coated surfaces under low-oxygen conditions and in the presence of growth media for the creation of a master cell bank (passage 4), a working cell bank (passage 6) and active substance (passage 9). The cells are adherent, secrete proangiogenic factors (including VEGF, IL-8 and CXCL5) and of mesenchymal progenitor lineage (in vitro differentiation to endothelial, hepatic and neuronal lineages). The cells express CD49c and CD90 (≥ 95% of the cells), and lack expression of CD45 and HLA II (<5%). Additional markers include >90% CD13, CD44, CD73, CD105 and <5% CD34)

MAPC

MULTIPOTENT ADULT PROGENITOR CELLS

MULTIPOTENT ADULT PROGENITOR CELLS (BONE MARROW DERIVED)

invimestrocel [INN]